Skip to content
2025Q4 Abbott Laboratories (ABT) episode artwork

Feb 22, 2026 33 min

2025Q4 Abbott Laboratories (ABT)

from Explain It to Me Please

Abbott Laboratories (NYSE: ABT) operates as a highly diversified global healthcare conglomerate, structured around four primary operating segments: Medical Devices, Diagnostics, Nutritional Products, and Established Pharmaceutical Products (EPD). The fundamental posture of the company as of early 2026 reflects a structural transition. Having fully cycled through the unprecedented revenue surges generated by COVID-19 rapid testing during the pandemic, the enterprise has successfully repositioned its growth engine toward its Medical Devices segment, particularly within continuous glucose monitoring (CGM) and electrophysiology. The analysis of Abbott’s fundamental standing requires a comprehensive review of its five-year financial performance, capital structure evolution, and the strength of its underlying economic moat.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

2025Q4 Abbott Laboratories (ABT)

0:00 33:56

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Explain It to Me Please?

This episode is 33 minutes long.

When was this Explain It to Me Please episode published?

This episode was published on February 22, 2026.

Can I download this Explain It to Me Please episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.